![Michael Brooks](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Brooks
President chez EDESA BIOTECH, INC.
Fortune : 76 507 $ au 31/05/2024
Postes actifs de Michael Brooks
Sociétés | Poste | Début | Fin |
---|---|---|---|
EDESA BIOTECH, INC. | President | 07/06/2019 | - |
Corporate Officer/Principal | 01/09/2015 | 01/01/2019 |
Historique de carrière de Michael Brooks
Anciens postes connus de Michael Brooks
Sociétés | Poste | Début | Fin |
---|---|---|---|
CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/01/2010 | 01/01/2015 |
Edesa Biotech Research, Inc. | Corporate Officer/Principal | 01/01/2015 | - |
Edesa Biotech, Inc. (Old)
![]() Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | President | 01/01/2015 | - |
Formation de Michael Brooks
University of Toronto | Doctorate Degree |
Rotman School of Management | Masters Business Admin |
Statistiques
Internationale
Canada | 7 |
Opérationnelle
Corporate Officer/Principal | 3 |
President | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
EDESA BIOTECH, INC. | Health Technology |
CIPHER PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Edesa Biotech, Inc. (Old)
![]() Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Health Technology |
Edesa Biotech Research, Inc. |
- Bourse
- Insiders
- Michael Brooks
- Expérience